Are branched-chain amino acids (BCAAs) recommended in AKI PN?

Prepare for the ASPEN Certified Nutrition Support Clinician (CNSC) Exam. Study with structured quizzes and detailed insights to enhance your knowledge and readiness. Get set for success!

Multiple Choice

Are branched-chain amino acids (BCAAs) recommended in AKI PN?

Explanation:
Branched-chain amino acids are not routinely recommended in PN for acute kidney injury because there’s no demonstrated benefit in this setting, and adding BCAAs can increase the nitrogen load the damaged kidneys must handle. In AKI, the goal is to provide a balanced amino acid profile that meets protein needs without unnecessarily elevating nitrogenous waste. BCAA-enriched formulas are primarily used for hepatic encephalopathy in liver disease, not AKI, so they don’t align with AKI PN goals. Therefore, the best approach is not to use BCAA-enriched PN in AKI. The other options imply selective or universal use, which isn’t supported by current practice in AKI PN.

Branched-chain amino acids are not routinely recommended in PN for acute kidney injury because there’s no demonstrated benefit in this setting, and adding BCAAs can increase the nitrogen load the damaged kidneys must handle. In AKI, the goal is to provide a balanced amino acid profile that meets protein needs without unnecessarily elevating nitrogenous waste. BCAA-enriched formulas are primarily used for hepatic encephalopathy in liver disease, not AKI, so they don’t align with AKI PN goals. Therefore, the best approach is not to use BCAA-enriched PN in AKI. The other options imply selective or universal use, which isn’t supported by current practice in AKI PN.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy